{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:02:11Z","timestamp":1762002131731,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ymgmr.2020.100685","type":"journal-article","created":{"date-parts":[[2020,12,13]],"date-time":"2020-12-13T07:10:42Z","timestamp":1607843442000},"page":"100685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Growth hormone as a rescue treatment in maple syrup urine disease with lessons from pediatric burn literature, case report and brief literature review"],"prefix":"10.1016","volume":"25","author":[{"given":"Brooke E.","family":"Kimbrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faith","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cortney B.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omayma A.","family":"Kishk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara A.","family":"Quinteros-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Eleni","family":"Nikita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol L.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ymgmr.2020.100685_bb0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ymgme.2020.01.006","article-title":"Branched-chain \u03b1-ketoacid dehydrogenase deficiency (maple syrup urine disease): treatment, biomarkers, and outcomes","volume":"129","author":"Strauss","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgmr.2020.100685_bb0010","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ymgme.2014.05.006","article-title":"Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach","volume":"112","author":"Frazier","year":"2014","journal-title":"Mol. Genet. Metab."},{"author":"Singh","key":"10.1016\/j.ymgmr.2020.100685_bb0015"},{"issue":"3","key":"10.1016\/j.ymgmr.2020.100685_bb0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/003591576806100335","article-title":"Maple syrup urine disease","volume":"61","author":"Hatcher","year":"1968","journal-title":"J. R. Soc. Med."},{"issue":"2","key":"10.1016\/j.ymgmr.2020.100685_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/bmmb.1994.1047","article-title":"Anabolic effect of human growth hormone: management of inherited disorders of catabolic pathways","volume":"52","author":"Marsden","year":"1994","journal-title":"Biochem. Med. Metabolic Biol."},{"issue":"2","key":"10.1016\/j.ymgmr.2020.100685_bb0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1515\/JPEM.2004.17.2.239","article-title":"Growth hormone deficiency associated with methylmalonic acidemia","volume":"17","author":"Al-Owain","year":"2004","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.ymgmr.2020.100685_bb0035","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1726-4901(09)70408-3","article-title":"Growth hormone therapy in neonatal patients with methylmalonic acidemia","volume":"72","author":"Kao","year":"2009","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.ymgmr.2020.100685_bb0040","first-page":"43","article-title":"Growth hormone therapy is safe and effective in patients with lysinuric protein intolerance","volume":"1","author":"Niinikoski","year":"2011","journal-title":"JIMD Rep."},{"issue":"4","key":"10.1016\/j.ymgmr.2020.100685_bb0045","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.burns.2014.10.010","article-title":"Effects of pharmacological interventions on muscle protein synthesis and breakdown in recovery from burns","volume":"41","author":"Diaz","year":"2015","journal-title":"Burns."},{"author":"Nyhan","key":"10.1016\/j.ymgmr.2020.100685_bb0050"},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100685_bb0055","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/0148607117711387","article-title":"Guidelines for the provision and assessment of nutrition support therapy in the pediatric critically ill patient: society of critical care medicine and American society of parenteral and enteral nutrition","volume":"41","author":"Mehta","year":"2017","journal-title":"JPEN"},{"year":"2015","series-title":"The ASPEN Pediatric Nutrition Support Core Curriculum","key":"10.1016\/j.ymgmr.2020.100685_bb0060"},{"year":"2020","series-title":"Genotropin\u00ae Subcutaneous Injection, Somatropin (rDNA Origin) Subcutaneous Injection","key":"10.1016\/j.ymgmr.2020.100685_bb0065"},{"issue":"6","key":"10.1016\/j.ymgmr.2020.100685_bb0070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000452150","article-title":"Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency","volume":"86","author":"Grimberg","year":"2016","journal-title":"Hormone Res. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgmr.2020.100685_bb0075","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1515\/JPEM.2005.18.4.363","article-title":"Activity of the growth hormone\/insulin-like growth factor-I Axis in critically ill children","volume":"18","author":"Gardelis","year":"2005","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"1\u20133","key":"10.1016\/j.ymgmr.2020.100685_bb0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000183772","article-title":"Acquired growth hormone resistance in patients with hypercatabolism","volume":"40","author":"Bentham","year":"1993","journal-title":"Horm. Res."},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100685_bb0085","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.beem.2011.06.002","article-title":"The GH\/IGF-1 system in critical illness","volume":"25","author":"Elijah","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgmr.2020.100685_bb0090","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJM199909093411102","article-title":"Increased mortality associated with growth hormone treatment in critically ill adults","volume":"341","author":"Takala","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100685_bb0095","first-page":"1868","article-title":"Critical evaluation of the safety of recombinant human growth hormone administration: statement from the growth hormone research society","volume":"86","year":"2001","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"10.1016\/j.ymgmr.2020.100685_bb0100","doi-asserted-by":"crossref","first-page":"28775","DOI":"10.1038\/srep28775","article-title":"Metformin inhibits Branched Chain Amino Acid (BCAA) derived ketoacidosis and promotes metabolic homeostasis in MSUD","volume":"6","author":"Sonnet","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426920301312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426920301312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:53:22Z","timestamp":1762001602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426920301312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":20,"alternative-id":["S2214426920301312"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100685","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth hormone as a rescue treatment in maple syrup urine disease with lessons from pediatric burn literature, case report and brief literature review","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100685"}}